Research programme: gastric disorder therapy - GC Pharma
Alternative Names: GC-7101Latest Information Update: 07 Feb 2018
At a glance
- Originator Green Cross
- Developer GC Biopharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gastric ulcer; Gastritis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Gastric-ulcer in South Korea
- 16 Jul 2016 No recent reports of development identified for preclinical development in Gastritis in South Korea
- 18 Apr 2011 Preclinical trials in Gastric ulcer in South Korea (unspecified route)